| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/06/2006 | US20060074078 Product comprising a transduction inhibitor of heterotrimeric G protein signals combined with another anti-cancer agent for therapeutic use in the treatment of cancer |
| 04/06/2006 | US20060074065 compounds enhance the activity of beta-lactam antibiotics; use to treat antibiotic resistance bacterial infections like otitis, sinusitis, meningitis etc. especially associated with Enterobacter, Citrobacter, and Serratia; Diphenylmethyl 7-phenylacetamido-3-(trifluorosulfonyloxy)-3-cephem-4-carboxylate |
| 04/06/2006 | US20060074064 Tricyclic 6-alkylidene-penems as beta-lactamase inhibitors |
| 04/06/2006 | US20060074036 Agents for gene therapy of cerebrovascular disorders |
| 04/06/2006 | US20060073569 Protease for identifying modulators for treatment and prevention of thrombocytopenia and liver disorders |
| 04/06/2006 | US20060073567 Novel insulin/IGF/relaxin family polypeptides and DNAs thereof |
| 04/06/2006 | US20060073522 Derived from ghrelin polypeptide, labelled with fluorochrome and cysteine; drug screening; high throughput assay |
| 04/06/2006 | US20060073516 Novel screening method |
| 04/06/2006 | US20060073498 GlcNAc phosphotransferase of the lysosomal targeting pathway |
| 04/06/2006 | US20060073222 Saponin mixtures and compounds isolated from Acacia victoriae; glycosides of acacic or oleanolic acid; control of cell apoptosis and cytotoxicity; antitumor, -carcinogenic, -inflammatory and -proliferative agents; atherosclerosis |
| 04/06/2006 | US20060073215 Cough depressant composition containing iron for angiotensin-converting enzyme inhibitor inducing cough |
| 04/06/2006 | US20060073187 Use of arachidonic acid for normalization of infradian rhythm |
| 04/06/2006 | US20060073176 Water-soluble composition containing coenzyme q10 |
| 04/06/2006 | US20060073167 Vaccine for fish cold-water disease |
| 04/06/2006 | US20060073162 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor |
| 04/06/2006 | US20060073150 monoclonal antibodies or antigen binding fragments that specifically to six transmembrane epithelial antigens of the prostate (STEAP-1), used for medical diagnosis, prognosis, prophylaxis and/or therapy for cancers |
| 04/06/2006 | US20060073146 Uses of agonists and antagonists to modulate activity of TNF-related molecules |
| 04/06/2006 | US20060073145 Methods and compositions for inhibiting CD14 mediated cell activation |
| 04/06/2006 | US20060073105 Novel dry powder inhalation system for transpulmonary administration |
| 04/06/2006 | CA2582777A1 Proton pump inhibitors |
| 04/06/2006 | CA2581922A1 1-(.beta.-d-glycopyranosyl)-3-substituted nitrogenous heterocyclic compound, medicinal composition containing the same, and medicinal use thereof |
| 04/05/2006 | EP1642979A1 Fucosyltransferase gene |
| 04/05/2006 | EP1642973A1 Therapeutic uses of BR43X2 soluble receptors |
| 04/05/2006 | EP1642972A1 Therapeutic uses of BR43X2 soluble receptors |
| 04/05/2006 | EP1642909A2 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
| 04/05/2006 | EP1642898A1 Heteroaryloxy nitrogenous saturated heterocyclic derivative |
| 04/05/2006 | EP1642888A1 compounds for modulating the rage receptor |
| 04/05/2006 | EP1642885A1 Use of a pharmaceutical composition containing a para-aminophenyl acetic acid derivative for treating inflammatory conditions of the gastrointestinal tract |
| 04/05/2006 | EP1642880A1 Hsp90 family protein inhibitors |
| 04/05/2006 | EP1642594A1 Remedy for urinary tract diseases |
| 04/05/2006 | EP1642589A1 Preventives/remedies for snore or respiratory disturbances during sleep |
| 04/05/2006 | EP1642584A1 External preparation for improving coital function |
| 04/05/2006 | EP1642576A2 Methods, kits and compositions for using pyrrole derivatives to combat anxiety |
| 04/05/2006 | EP1642575A1 Use of r-nsaid's for the prevention of alzheimer's disease |
| 04/05/2006 | EP1642573A1 Use of GABA B receptor modulators for treating gastro-intestinal disorders |
| 04/05/2006 | EP1641775A1 2-pyridine alkyne derivatives useful for treating pain |
| 04/05/2006 | EP1641493A1 Radiolabeled cannabinoid-1 receptor modulators |
| 04/05/2006 | EP1641434A1 Pharmaceutical formulations for intranasal administration of protein comprising chitosan or a derivative thereof |
| 04/05/2006 | EP1641431A2 Uses of il-12 in hematopoiesis |
| 04/05/2006 | EP1524975B1 Improved transdermal delivery system for the administration of rotigotine |
| 04/05/2006 | EP1450822A4 Polymeric thiol-linked prodrugs |
| 04/05/2006 | EP1438104B1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists |
| 04/05/2006 | EP1435235B1 Use of hydroxyoleic acid and similar compounds in the production of medicaments |
| 04/05/2006 | EP1392308B1 Ophthalmically acceptable compositions comprising an alpha-2-adrenergic agonist and a fatty acid |
| 04/05/2006 | EP1383522B1 A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of inflammatory skin conditions |
| 04/05/2006 | EP1320361A4 Method for reducing exacerbations associated with copd |
| 04/05/2006 | EP1307197B1 Compositions for the treatment of cancer comprising a topoisomerase inhibitor and thalidomide |
| 04/05/2006 | EP1305319B1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 04/05/2006 | EP1294720B1 Non-nucleoside reverse transcriptase inhibitors |
| 04/05/2006 | EP1286671B1 Compositions for the treatment of colorectal cancer comprising thalidomide and irinotecan |
| 04/05/2006 | EP1280524B1 Methods and compositions for modulating alpha adrenergic receptor activity |
| 04/05/2006 | EP1244667B1 Cyclohexene nucleic acids |
| 04/05/2006 | EP1173427B1 Hydroxamic acid derivative |
| 04/05/2006 | EP1140192B1 Use of the cyclooxygenase-2 inhibitor celecoxib and capecitabine for combination therapy in neoplasia |
| 04/05/2006 | EP1094824B1 Prophylactic and therapeutic nutritional supplement for creation/maintenance of health-protective intestinal microflora and enhancement of the immune system |
| 04/05/2006 | EP1086098B1 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists |
| 04/05/2006 | EP1085901B1 Transdermal use of secretin for the treatment of autism |
| 04/05/2006 | EP1019372B1 Fused pyrrolecarboxamides; a new class of gaba brain receptor ligands |
| 04/05/2006 | EP0981514B1 3-epi vitamin d2 compounds and uses thereof |
| 04/05/2006 | EP0800397B1 Bone mass anabolic composition comprising olpadronate |
| 04/05/2006 | CN1756753A Benzofuran derivative |
| 04/05/2006 | CN1756750A Adiponectin expression promoter |
| 04/05/2006 | CN1756740A Nitrogenous heterocyclic derivative having 2,6-disubstituted styryl |
| 04/05/2006 | CN1756567A Body weight gain inhibitor |
| 04/05/2006 | CN1756544A Use of arachidonic acid for normalization of infradian rhythm |
| 04/05/2006 | CN1754880A Process for preparing 2-iminopyrrolidine derivatives |
| 04/05/2006 | CN1754562A Quality control method for children hyperkinetic symptom therapeutic traditional Chinese medicine formulation |
| 04/05/2006 | CN1754560A Soft capsule containing extract of tree peony bar and cape jasmine and its preparation method |
| 04/05/2006 | CN1249087C Novel human G-Protein coupled receptor |
| 04/05/2006 | CN1249086C Melanocortin receptor ligands |
| 04/05/2006 | CN1249074C 2-aminocarbonyl-9H-punine derivatives |
| 04/05/2006 | CN1249066C 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 04/05/2006 | CN1249063C Immunoregulatory compounds |
| 04/05/2006 | CN1249062C Substituted imidazopyridines |
| 04/05/2006 | CN1249059C Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 04/05/2006 | CN1249058C Perfluoroalkyl-containing complexes with sugar radicals, process for their production and their use |
| 04/05/2006 | CN1249056C Inhibitors of dipeptidyl peptidase IV |
| 04/05/2006 | CN1249055C Piperazinylcarbonylquinolines and -isoquinolines |
| 04/05/2006 | CN1249043C New heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 04/05/2006 | CN1249039C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type I |
| 04/05/2006 | CN1249036C Iron chelators and use thereof |
| 04/05/2006 | CN1249033C Cyclic amp-specific phosphodiesterase inhibitors |
| 04/05/2006 | CN1249026C N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 04/05/2006 | CN1248974C Titanium-group metal containing high-performance water, and its producing method and apparatus |
| 04/05/2006 | CN1248712C Medicine composition for treating splenomegaly and its preparation method |
| 04/05/2006 | CN1248692C Use of corpus vitreum conjugated protein receptor antagon in preparation of medicine for inhibiting accretion generation |
| 04/05/2006 | CN1248686C Application of 5-amino-levulinic acid in swine growth promoters |
| 04/05/2006 | CN1248591C Cooling and heatstroke-eliminating tea and its preparation |
| 04/04/2006 | US7022856 Carboline derivatives |
| 04/04/2006 | US7022852 such as 1-C-(5-N-benzyloxymethyl-4-methoxy pyrrolo[3,2-d]pyrimidin-7-yl)-1,4-dideoxy-1,4-imino-2,3-O-isopropylidene-D-ribitol; potent inhibitors of purine nucleoside phosphorylase and useful for suppressing T-cell function and/or treating and/or preventing infections caused by protozoan parasites |
| 04/04/2006 | US7022849 Quinazoline and pyrido[2,3-d]pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| 04/04/2006 | US7022818 of given amino acid sequence; use as a target for drug screening of antagonists or agonists of said receptor; receptor can bind persephin |
| 04/04/2006 | US7022738 (3S)-N-butyl-3-((2S)-2-(((4-fluorophenyl)sulfonyl)amino)-3-methylbutanoylamino)-5-methyl-2-oxohexanamide; calpain inhibition; Alzheimer's, osteoporosis, brain and eye disorders, ischemia |
| 04/04/2006 | US7022731 Cardiovascular disorders; thrombosis; anticoagulants |
| 04/04/2006 | US7022730 Protein tyrosine phosphatases inhibitors |
| 04/04/2006 | US7022729 For treating central nervous system disorders, immunomodulatory disorders, antimalaria, viral disease of Borna virus, Hepatitis; a 6-azatricyclo(6.3.1.01,6)dodecane derivatives |
| 04/04/2006 | US7022717 Chemokine receptor binding heterocyclic compounds |
| 04/04/2006 | US7022716 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 04/04/2006 | US7022715 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 04/04/2006 | US7022711 2-(4-Pyridyl)amino-6-dialkoxyphenyl-pyrido[2,3-d]pyrimidin-7-ones |